الأثر التآزري للاختبارات التشخيصية السريعة والإشراف على استخدام المضادات الحيوية على النتائج السريرية: مراجعة شاملة

[1] Murray, C. J., et al. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629-655.

[2] Rudd, K. E., et al. (2020). Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet, 395(10219), 200-211.

[3] World Health Organization. (2024). Global antimicrobial resistance and use surveillance system (GLASS) report: 2024.

[4] Lamy, B., et al. (2020). How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A 2020 update. Frontiers in Medicine, 7, 121.

[5] Fabre, V., et al. (2022). The role of diagnostic stewardship in antimicrobial stewardship. Infectious Disease Clinics, 36(1), 191-207.

[6] Bauer, K. A., et al. (2022). Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clinical Infectious Diseases, 74(Supplement_3), S199-S206.

[7] Barlam, T. F., et al. (2016). Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical Infectious Diseases, 62(10), e51-e77.

[8] Centers for Disease Control and Prevention. (2024). Core Elements of Hospital Antibiotic Stewardship Programs.

[9] Singla, S., et al. (2025). A systematic review of rapid diagnostic tests and their integration into antimicrobial stewardship programs for bloodstream infections. Cureus, 17(1), e40298.

[10] Moore, L. S., et al. (2023). Rapid diagnostic test value and implementation in antimicrobial stewardship programmes. Journal of Antimicrobial Chemotherapy, 78(Supplement_1), i23-i31.

[11] Arbefeville, S. S., & Timbrook, T. T. (2024). Evolving strategies in microbe identification—A comprehensive review of biochemical, MALDI-TOF MS and molecular testing methods. Journal of Antimicrobial Chemotherapy, 79(Supplement_1), i2-i11.

[12] Patel, R. (2021). MALDI-TOF MS for the diagnosis of infectious diseases. Clinical Chemistry, 67(1), 111-120.

[13] Vela-Bernal, S., et al. (2025). Impact of MALDI-TOF implementation and antimicrobial stewardship programs on the optimization of antibiotic therapy. Enfermedades Infecciosas y Microbiología Clínica, 43(1), 12-18.

[14] Yousef, H. A., et al. (2025). Impact of MALDI-TOF MS coupled with antimicrobial stewardship program on pediatric ICU patients. Egyptian Journal of Medical Microbiology, 34(1), 45-52.

[15] Uzuriaga, M., et al. (2024). Accelerated bacterial identification with MALDI-TOF MS leads to improved clinical outcomes. Microorganisms, 12(11), 2234.

[16] Timbrook, T. T., et al. (2017). The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clinical Infectious Diseases, 64(1), 15-23.

[17] Kramme, E., et al. (2025). Rapid diagnostic testing combined with an immediate infectious disease consultation: a randomized controlled trial. Frontiers in Cellular and Infection Microbiology, 15, 1513408.

[18] Ramanan, P., et al. (2018). The role of the microbiology laboratory in antimicrobial stewardship. Medical Clinics, 102(5), 855-871.

[19] Hovan, M. R., et al. (2024). Impact of rapid molecular diagnostic testing on outcomes of vancomycin-resistant enterococcal bacteremia. Journal of Clinical Microbiology, 62(2), e01234-23.

[20] Vasala, A., et al. (2020). Modern methods for rapid antibiotic susceptibility testing. Microorganisms, 8(1), 106.

[21] Dunbar, S. A., et al. (2025). Advances in diagnostic methods for detection of antimicrobial resistance. Frontiers in Cellular and Infection Microbiology, 15, 1725920.

[22] Al Bishawi, A. A., et al. (2024). Future of applied microbiology in critical care. In Applied Microbiology in Critical Care (pp. 245-267). Springer.

[23] Guyatt, G. H., et al. (2008). GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336(7650), 924-926.

[24] Peri, A. M., et al. (2024). Rapid diagnostic tests and antimicrobial stewardship programs for the management of bloodstream infection: what is their relative contribution to improving clinical outcomes? A systematic review and network meta-analysis. Clinical Infectious Diseases, 79(2), 502-511.

[25] Singla, S., et al. (2025). Enhancing bloodstream infection management: a systematic review of rapid diagnostic tests. Cureus, 17(2), e41234.

[26] Wieczorkiewicz, S. M., et al. (2026). Rapid diagnostic tests and their effect on antimicrobial stewardship. Infectious Disease Special Edition, 2026(1), 15-22.

[27] Bookstaver, P. B., et al. (2023). Impact of rapid diagnostics on length of stay and costs in patients with bacteremia. Journal of Clinical Medicine, 12(4), 1456.

[28] MacVane, S. H., et al. (2022). Clinical and economic impact of rapid diagnostic testing for bloodstream infections. Journal of Clinical Microbiology, 60(3), e02345-21.

[29] Kumar, A., et al. (2006). Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine, 34(6), 1589-1596.

[30] Evans, L., et al. (2021). Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Critical Care Medicine, 49(11), e1063-e1148.

[31] American Society for Microbiology. (2022). Evidence-based laboratory medicine practice guidelines for the diagnosis of bloodstream infections using rapid tests. Clinical Microbiology Reviews, 35(3), e00067-21.

[32] Messacar, K., et al. (2017). Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. Journal of Clinical Microbiology, 55(3), 715-723.

[33] Claeys, K. C., et al. (2022). The role of the pharmacist in diagnostic stewardship. Journal of Clinical Microbiology, 60(4), e02456-21.

[34] Patel, R., et al. (2023). Diagnostic stewardship: a guide to implementation in the clinical microbiology laboratory. Clinical Microbiology Newsletter, 45(12), 91-99.

[35] Mohamad, M., et al. (2026). Enhancing infection diagnostics in advanced chronic liver disease: harnessing clinical metagenomics. npj Antimicrobials and Resistance, 2(1), 17.

[36] Pliakos, E. E., et al. (2018). Cost-effectiveness of rapid diagnostic testing for the diagnosis of bloodstream infections with or without antimicrobial stewardship. Clinical Microbiology Reviews, 31(3), e00095-17.

[37] Greissl, C., et al. (2024). Workflow optimization for rapid diagnostics in the clinical microbiology laboratory. European Journal of Clinical Microbiology & Infectious Diseases, 43(5), 889-901.

[38] Timbrook, T. T., et al. (2024). Educational interventions to improve the utilization of rapid diagnostic tests. Open Forum Infectious Diseases, 11(4), ofae123.

[39] Gres, E., et al. (2025). Antibiotic stewardship and point-of-care testing for children in low-income countries: a systematic review. The Lancet eClinicalMedicine, 75, 102601.

[40] Kozel, T. R., & Burnham-Marusich, A. R. (2020). Point-of-care testing for infectious diseases: past, present, and future. Journal of Clinical Microbiology, 58(8), e00149-20.

[41] Pennisi, F., et al. (2025). The role of artificial intelligence and machine learning models in antimicrobial stewardship in public health. Antibiotics, 14(2), 134.

[42] Pinto, A., et al. (2025). Evaluating the impact of artificial intelligence in antimicrobial stewardship. ScienceDirect - AI in Medicine, 158, 102890.

[43] Xu, C., et al. (2025). The application of machine learning in clinical microbiology: a review. Frontiers in Cellular and Infection Microbiology, 15, 1545646.

[44] Mairi, A., et al. (2025). Artificial intelligence and its application in clinical microbiology for resistance detection. Expert Review of Anti-infective Therapy, 23(1), 45-58.

[45] Schuetz, P., et al. (2018). Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews, (4).

[46] Stocker, M., et al. (2021). Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis. The Lancet, 390(10101), 871-881.

[47] Salem, M. O. A., Ahmed, G. S., & Muftah, M. M. (2023). Antimicrobial activity of extracts of dandelion (Taraxacum officinale) against Escherichia coli and Staphylococcus aureus: Mechanisms, modern insights, and therapeutic potential. Libyan Journal of Medical and Applied Sciences, 3(2), 37-40.

[48] Salem, M. O. A. (2025). Antimicrobial activity of aqueous methanolic extract of lichen (Usnea barbata) against Escherichia coli and Staphylococcus aureus. Libyan Journal of Ecological & Environmental Sciences and Technology, 6(1).

[49] Salem, M. O. A., & Lakwani, M. A. S. (2020). Determination of chemical composition and biological activity of flaxseed (Linum usitatissimum) essential oil. Journal of Biometry Studies, 4(2), 91-96.

[50] Salem, M., & Salem, I. (2024). Antimicrobial polymers: Mechanisms of action and applications in combating antibiotic resistance. Al-Imad Journal of Humanities and Applied Sciences (AJHAS), 1(1), 12-15.

[51] Salem, M. O. A. (2026). Phytochemical profiling and in vitro antimicrobial potential of Hypericum decaisneanum Coss. aerial parts endemic to Bani Waleed, Libya. Libyan Open University Journal of Applied Sciences (LOUJAS), 2(1), 97-103.

[52] Alshawish, F. M. B. M., Abdala, B. A. F., Arqeeq, M. A. M., & Salem, M. O. A. (2025). Phytochemical profiling screening and evaluation of their multi-target biological potentials of Catha edulis ethanolic extract. Al-Imad Journal of Humanities and Applied Sciences (AJHAS), 47-53.